Merck to acquire Terns Pharmaceuticals for USD6.7bn

Philips launches integrated IntraSight Plus platform to enhance coronary intervention efficiency

Hope Medicine reports first patient dosed in Phase III trial of HMI-115

Orsini chosen as single-source specialty pharmacy partner for Glaukos' Epioxa

GE HealthCare's Photonova Spectra gains FDA clearance

Futura Medical reports positive home user test results for Eroxon and Intense variant

GSK secures Japan Orphan Drug status for lung cancer ADC

Belief BioMed enters exclusive partnership with Grand Life Sciences for haemophilia A treatment

Glaukos launches Epioxa to advance incision-free treatment for keratoconus

Sanofi's venglustat receives FDA Breakthrough Therapy designation for type 3 Gaucher disease

Sentynl Therapeutics and PRG S&T enter licensing agreement for potential HGPS treatment

CMIC agrees agentic AI partnership with Bluenote

Biofrontera reports Phase 2b data for Ameluz photodynamic therapy in acne vulgaris treatment

Precision BioSciences receives FDA Fast Track designation for PBGENE-DMD

AstraZeneca and Daiichi Sankyo's Enhertu receives US priority review for post-neoadjuvant HER2-positive early breast cancer